10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 2 (20%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 6 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GROSS, JASON PATRICK | 1 | 63.6% | +48.3% |
| BARRON, SEAN C | 1 | 53.3% | +30.6% |
| MCDOWELL, BRIAN E | 1 | 74.2% | +30.4% |
| PERSONS, JENNA L | 1 | 50.0% | +60.0% |
| BUTTICE, AUDREY L | 1 | 47.1% | +26.0% |
| BRADLEY, CHRISTINA | 1 | 62.8% | +33.2% |
| BARSKY, JARED | 1 | 50.3% | +23.1% |
| LUSI, ELLIS FOLLETT | 1 | 64.3% | +52.8% |
| BAKSHI, PANCHAM | 1 | 77.0% | +30.2% |
| KOLTONOW, ANDREW ROBERT | 1 | 46.3% | +33.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700200 | GIANT ORGANELLES RECOVERY AND USE THEREOF | BARRON, SEAN C | 21d |
| 18032817 | METHOD FOR EVALUATING THE MECHANOBIOLOGICAL PROPERTIES OF A CELL ELEMENT | LUSI, ELLIS FOLLETT | 34d |
| 18684600 | NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS | MCDOWELL, BRIAN E | — |
| 18575442 | METHODS FOR IMPROVING RELAXATION OF STRIATED MYOCYTES | PERSONS, JENNA L | — |
| 18571893 | USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME | BUTTICE, AUDREY L | — |
| 18552054 | TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME | BRADLEY, CHRISTINA | — |
| 17797682 | REVERSE ELECTRO-OSMOTIC FILTRATION SYSTEM AND USES THEREOF | KOLTONOW, ANDREW ROBERT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18700200 | GIANT ORGANELLES RECOVERY AND USE THEREOF | BARRON, SEAN C | 21d |
| 18032817 | METHOD FOR EVALUATING THE MECHANOBIOLOGICAL PROPERTIES OF A CELL ELEMENT | LUSI, ELLIS FOLLETT | 34d |
| 19078397 | Efficient Magnetic Resonance Elastography using Interleaved Motion Encoding | GROSS, JASON PATRICK | — |
| 18684600 | NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS | MCDOWELL, BRIAN E | — |
| 18575442 | METHODS FOR IMPROVING RELAXATION OF STRIATED MYOCYTES | PERSONS, JENNA L | — |
| 18571893 | USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME | BUTTICE, AUDREY L | — |
| 18552054 | TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME | BRADLEY, CHRISTINA | — |
| 18266499 | EMBOLIZING EMULSION FOR TREATMENT OF INFLAMMATORY HYPERVASCULARIZATION ASSOCIATED WITH MUSCULOSKELETAL DISORDERS | BARSKY, JARED | — |
| Art Unit | Apps |
|---|---|
| 3797 | 1 |
| 1653 | 1 |
| 1624 | 1 |
| 1654 | 1 |
| 1628 | 1 |
| 1677 | 1 |
| 1623 | 1 |
| 1700 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19078397 | Efficient Magnetic Resonance Elastography using Interleaved Motion Encoding | GROSS, JASON PATRICK | 3797 | §103 | Non-Final OA | — | Pending | Mar 13, 2025 |
| 18700200 | GIANT ORGANELLES RECOVERY AND USE THEREOF | BARRON, SEAN C | 1653 | §103§112 | Final Rejection | 21d | Pending | Apr 10, 2024 |
| 18684600 | NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS | MCDOWELL, BRIAN E | 1624 | §102§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18575442 | METHODS FOR IMPROVING RELAXATION OF STRIATED MYOCYTES | PERSONS, JENNA L | — | §101§102§112 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18571893 | USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME | BUTTICE, AUDREY L | — | §102§103§112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18552054 | TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME | BRADLEY, CHRISTINA | 1654 | §103§112 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18266499 | EMBOLIZING EMULSION FOR TREATMENT OF INFLAMMATORY HYPERVASCULARIZATION ASSOCIATED WITH MUSCULOSKELETAL DISORDERS | BARSKY, JARED | 1628 | §103 | Final Rejection | — | Pending | Jun 09, 2023 |
| 18032817 | METHOD FOR EVALUATING THE MECHANOBIOLOGICAL PROPERTIES OF A CELL ELEMENT | LUSI, ELLIS FOLLETT | 1677 | §103§112 | Non-Final OA | 34d | Pending | Apr 20, 2023 |
| 18001184 | FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY | BAKSHI, PANCHAM | 1623 | §112DP | Final Rejection | — | Pending | Dec 08, 2022 |
| 17797682 | REVERSE ELECTRO-OSMOTIC FILTRATION SYSTEM AND USES THEREOF | KOLTONOW, ANDREW ROBERT | 1700 | §102§103§112 | Non-Final OA | — | Pending | Aug 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial